ConductScience.org, home

Paper7204579

In vivo effects of protease inhibitors on chickens with hereditary muscular dystrophy.

Hudecki MS and 2 others. J Clin Invest, 1981. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vivo effects of protease inhibitors on chickens with hereditary muscular dystrophy. Papers, record 7204579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7204579

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo effects of protease inhibitors on chickens with hereditary muscular dystrophy.
PubMed
Journal
J Clin Invest
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2019-06-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hudecki MSM S
2Pollina CMC M
3Heffner RRR R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Muscular Dystrophy, AnimalMajor topic
Protease InhibitorsMajor topic
Animals
Body Weight
Chickens
Creatine Kinase
Female
Male
Organ Size
Postural Balance

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14645753Proteolytic activity during growth of hypertrophic and atrophic muscles of genetically dystrophic chickens.Proc Soc Exp Biol Med1972https://conductscience.org/library/papers/4645753PubMed
2212765Brief communication. Hind limb extensor response: a method for assessing motor dysfunction in rats.Pharmacol Biochem Behav1978https://conductscience.org/library/papers/212765PubMed
36448038Screening of antiserotoninergic drugs with the genetically dystrophic chicken.Arch Neurol1980https://conductscience.org/library/papers/6448038PubMed
4635570Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.Science1978https://conductscience.org/library/papers/635570PubMed
516749029Biochemistry of dystrophic muscle. 2. Some enzyme changes in dystrophic mouse muscle.Biochem J1963https://conductscience.org/library/papers/16749029PubMed
61253868Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain.Exp Neurol1976https://conductscience.org/library/papers/1253868PubMed
7556824Serum creatine phosphokinase levels and prednisone treated muscle weakness.Neurology1977https://conductscience.org/library/papers/556824PubMed
8680074Effect of exercise on chickens with hereditary muscular dystrophy.Exp Neurol1978https://conductscience.org/library/papers/680074PubMed
96251364Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils.Muscle Nerve1980https://conductscience.org/library/papers/6251364PubMed
104800933Serum enzyme alterations in neuromuscular disorders.JAMA1973https://conductscience.org/library/papers/4800933PubMed
11625478A simple recording grip strength device.Pharmacol Biochem Behav1978https://conductscience.org/library/papers/625478PubMed
125072697Cathepsins A, B, C, D and autolysis during development of breast muscle of normal and dystrophic chickens.Arch Biochem Biophys1972https://conductscience.org/library/papers/5072697PubMed
13545142Delayed functional disability in dystrophic chickens receiving chemotherapy.Muscle Nerve1979https://conductscience.org/library/papers/545142PubMed
14622552Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.Science1978https://conductscience.org/library/papers/622552PubMed
15710572Righting ability and skeletal muscle properties of phenytoin-treated dystrophic chickens.Exp Neurol1978https://conductscience.org/library/papers/710572PubMed
1635747Muscular dystrophy and activation of proteinases.Muscle Nerve1978https://conductscience.org/library/papers/35747PubMed
17660216Treatment of mouse muscular dystrophy with the protease inhibitor pepstatin.J Neuropathol Exp Neurol1978https://conductscience.org/library/papers/660216PubMed
1811385The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscle.Life Sci1976https://conductscience.org/library/papers/11385PubMed
19337944Therapeutic trials in muscular dystrophy. III. Studies of microbial proteinase inhibitors in murine dystrophy.Arch Neurol1977https://conductscience.org/library/papers/337944PubMed
205313881Cathepsin activity in normal and dystrophic human muscle.Enzymol Biol Clin (Basel)1968https://conductscience.org/library/papers/5313881PubMed

See all 24 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn Papers
7158305Therapeutic trial with protease inhibitor (leupeptin) in chicken muscular dystrophy. A histologic and histochemical study.Acta Neuropathol1982https://conductscience.org/library/papers/7158305

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7204579

GET https://conductscience.org/api/papers/v1/7204579/references?page=2